Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data VNUE, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2015
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Revenue
0.04
0.08
0.21
0.1
0.36
0.53
Gross profit
2.54
-0
0.01
-0.05
0.03
0.18
Research and development
0.1
0.55
1.11
0.12
0.01
0.01
0
General and administrative
0.16
2.32
1.27
0.89
0.96
1.18
0.6
0.15
0.5
0.35
Operating expenses
0.26
4.05
2.37
1.04
1.28
Operating income
-0.26
-4.05
-2.37
-1.01
-1.2
-1.33
-0.59
-0.98
-21.8
-1.41
Interest expense
0.01
0.02
Other non-operating income
-0.22
-0.22
-0.19
-1.15
-0.07
-3.97
3.91
-0.95
0.27
Net income
-0.39
-4.27
-2.6
-1.19
-2.36
-1.4
-4.55
2.92
-22.8
-1.14
EBITDA
-0.98
-21.8
-1.4
EPS, basic
0.00
-0.01
-0.04
-0.02
-0.03
0.00
0.00
-0.02
0.00
EPS, diluted
0.00
-0.01
-0.04
-0.02
-0.03
0.00
0.00
-0.02
0.00
Shares, basic (weighted)
402
542
68
69
89.2
447
1,135
Shares, diluted (weighted)
402
542
68
69
89.2
447
1,135
Balance sheet
FY2015
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Cash and equivalents
0
0.01
0.02
0.01
0.02
0.05
0
0.04
0.08
0.03
Other current assets
0
0.04
0
0
0
0.1
0.46
0.13
0
Total current assets
0
0.05
0.02
0.01
0.02
0.05
0.1
0.5
0.21
0.03
Property, plant and equipment
0
0.01
0
Intangible assets
0.34
0.32
0.23
0
Total assets
0.34
0.05
0.02
0.33
0.25
0.05
0.1
0.5
0.22
0.03
Accounts payable
0.11
0.23
0.45
0.66
0.67
1.02
2.37
0.92
2.82
2.42
Accrued liabilities
0
0.13
0.7
0.51
0.05
0.27
0.47
0.19
0.28
0.3
Total current liabilities
0.19
0.77
1.93
2.78
4.01
3.83
8.35
3.29
6.68
6.61
Total liabilities
0.42
0.77
1.93
3.08
4.31
3.83
8.35
3.29
6.68
6.61
Paid-in capital
0.26
3.74
4.33
4.76
6.49
8.1
8.39
10.9
30.2
31.4
Retained earnings
-0.39
-4.65
-7.25
-8.45
-10.8
-12.2
-16.8
-13.8
-36.8
-38.2
Treasury stock
-10
Shareholders' equity
-0.08
-0.72
-1.91
-2.75
-4.05
-4.03
-8.25
-2.79
-6.46
-6.58
Minority interests
1.85
Total equity
-0.08
-0.72
-0.06
-2.75
-4.05
-4.03
-8.25
-2.79
-6.46
-6.58
Total liabilities and equity
0.34
0.05
0.02
0.33
0.25
0.05
0.1
0.5
0.22
0.03
Shares outstanding
402
641
64.5
74.3
106
771
1,211
1,412
1,676
2,646
Cash flow statement
FY2015
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Net income
-0.39
-4.27
-2.6
-1.19
-2.36
-1.4
-4.55
2.92
-22.8
-1.14
Depreciation and amortization
0
0.03
0.01
Stock-based compensation
1.09
0.55
15.3
0.38
Change in payables
0.11
0.13
0.23
0.21
0.26
0.13
1.4
-1.05
0.19
-0.29
Cash from operations
-0.13
-0.83
-0.31
-0.44
-0.58
-0.5
-0.52
-1.43
-1.28
-1.08
Capital expenditures
-0.05
Cash from investing
-0.15
-0.05
-0.05
0
0
-0.98
Debt issued
0.08
0.54
0.52
0.33
0
Debt repaid
-0
Stock issued
0.1
0.95
Dividends paid
-0.21
-0.29
Cash from financing
0.28
0.89
0.32
0.48
0.58
0.54
0.47
1.46
2.3
1.03
Net change in cash
0.01
0.03
-0.05
0.03
0.05
-0.06
Free cash flow
-0.49
Interest paid
0
0
0
Income taxes paid
0
0
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2024; growth uses fiscal years. Valuation uses the share price of $0.01 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
49.9%
Gross profit / revenue.
Operating margin
-612.2%
Operating income / revenue.
EBITDA margin
-612.2%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
-508.0%
Net income / revenue.
Operating cash flow margin
-117.1%
Cash from operations / revenue.
Return on assets (ROA)
-52,449.0%
Net income / average total assets.
D&A / revenue
0.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
47.4%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 5y
44.9%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
449.0%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
135.6%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
-88.5%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-37.6%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-36.8%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.00x
Current assets / current liabilities.
Quick ratio
0.00x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.00x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.00
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.00
Cash from operations / diluted weighted shares.
Book value per share
-$0.00
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
83.8x
Market cap / revenue.
EV/Sales
83.8x
Enterprise value / revenue.
Earnings yield
-6.1%
Net income / market cap (the inverse of P/E).
What was VNUE, Inc.'s revenue in fiscal 2023?
VNUE, Inc. reported revenue of $529.4K for fiscal 2023, 47.4% higher than the year before.
Was VNUE, Inc. profitable in fiscal 2023?
No. It reported a net loss of $1.1M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.